Analyst Mitchell Kapoor from H.C. Wainwright reiterated a Hold rating on Zura Bio (ZURA – Research Report) and keeping the price target ...
Additionally, IK-595 shows potential for synergistic effects with various anticancer agents, enhancing its therapeutic prospects. Although the removal of IK-930 has impacted the stock’s valuation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback